Fortuna Mining Corp. Common Shares vs Indivior Pharmaceuticals Inc. Common Stock — how do they compare? Fortuna Mining Corp. Common Shares trades at $10.16 (market cap $3.12B), while Indivior Pharmaceuticals Inc. Common Stock trades at $34.01 (market cap $4.18B). The key difference: Indivior Pharmaceuticals Inc. Common Stock is the larger of the two by market cap, and Indivior Pharmaceuticals Inc. Common Stock is trading nearer its 52-week high, Fortuna Mining Corp. Common Shares nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Fortuna Mining Corp. Common Shares for 6 Days and Indivior Pharmaceuticals Inc. Common Stock for 0 Days on average.
| FSM | INDV | |
|---|---|---|
Market Cap | $3.12B | $4.18B |
Volume | 2,648,950 | 1,819,746 |
Sector | Basic Materials | Health |
52-Week High | $13.66 | $41.83 |
52-Week Low | $7.84 | $24.09 |
Typical Hold Time | 6 Days | 0 Days |
Enterprise Value | $2.74B | $4.47B |
Signals from Pluang's Aura AI — not financial advice
Fortuna Mining (FSM) trades at $10.58, down 1.67% on the day, amid a bearish technical signal. The company reported strong 2025 results with $947M revenue and $287M net income, but recent quarters have missed EPS expectations. Analyst consensus is bullish with 4 buy ratings, while technical indicators show mixed signals with a bearish moving average trend but neutral oscillators.
FSM presents a value opportunity with low P/E of 8.89 and robust profitability margins, but faces risks from production volatility and execution of growth projects. The stock's near-term performance hinges on Q3 2026 earnings and progress toward its 500,000-ounce gold production target by 2028.
No Aura AI signal available yet.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Fortuna Mining is a Canadian precious-metals mining company with operations in Latin America and West Africa. It produces gold and silver and conducts exploration activities in several countries.
Read more on FSM →Indivior Pharmaceuticals, Inc. is a pharmaceutical company focused on treatments for opioid use disorder and other addiction-related conditions, including its Suboxone film and tablet products.
Read more on INDV →